5-Amino-1MQ 10mg/vial 90 Day Protocol
High-purity research compound from DNAxis
$900.00
Top 5 Benefits and Uses
Increases NAD⁺ availability by inhibiting NNMT activity
Enhances fat loss by promoting mitochondrial energy expenditure
Improves insulin sensitivity and glucose regulation
Reduces adipocyte size in obesity models
Explored for longevity and metabolic syndrome mitigation
5-Amino-1MQ (5-Amino-1-methylquinolinium) is a small molecule derivative of 1-methylquinolinium that emerged from research focused on metabolic regulation and nicotinamide methyltransferase (NNMT) inhibition. Initially studied in cellular metabolism and obesity models, 5-Amino-1MQ was designed to inhibit NNMT, a key enzyme that regulates nicotinamide levels, energy expenditure, and cellular methylation. Its potential to reverse metabolic dysfunction and influence body composition has made it a focal point in obesity and longevity research.
Discover premium-grade 5-Amino-1MQ, each sealed glass vial contains 10mg of pure research compound manufactured by DNAxis for reliable laboratory and scientific research use. Designed to maintain optimal purity and stability, the clear, easy-to-handle vial ensures every dose is protected from contamination. Perfect for researchers seeking trustworthy quality and consistent results in their experiments, this product adheres to high manufacturing standards. Vial dimensions: approx. 2ml capacity, transparent glass with secure cap for added safety and convenience.
All peptide sales are final. Due to the sensitive nature of research peptides, we cannot accept returns or issue refunds once an order has been placed. This policy ensures product integrity, safety, and compliance. Please review your order carefully before completing your purchase.
Disclaimer: All peptide purchases require and include an initial consultation. Peptides are sold for research and educational purposes only. They are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any condition. By purchasing, you agree to these terms.